Bill
Bill > S3815
NJ S3815
NJ S3815Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.
summary
Introduced
05/11/2023
05/11/2023
In Committee
05/11/2023
05/11/2023
Crossed Over
Passed
Dead
01/08/2024
01/08/2024
Introduced Session
2022-2023 Regular Session
Bill Summary
This bill requires health insurers (health, hospital, and medical service corporations, commercial individual and group health insurers, health maintenance organizations, health benefits plans issued pursuant to the New Jersey Individual Health Coverage and Small Employer Health Benefits Programs, the State Health Benefits Program, and the School Employees' Health Benefits Program) to provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.
AI Summary
This bill requires health insurers (including hospital service corporations, medical service corporations, health service corporations, individual and group health insurers, health maintenance organizations, and government health plans) to provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by a health care practitioner, for the treatment of glycogen storage disease. The benefits must be provided to the same extent as for any other medical condition under the plan, and the bill applies to all health benefits plans delivered, issued, executed, or renewed in New Jersey on or after the effective date.
Committee Categories
Business and Industry
Sponsors (3)
Last Action
Introduced in the Senate, Referred to Senate Commerce Committee (on 05/11/2023)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2022/S3815 |
| BillText | https://pub.njleg.gov/Bills/2022/S4000/3815_I1.HTM |
Loading...